fluorobenzenes has been researched along with Insulin Resistance in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.78) | 18.2507 |
| 2000's | 13 (36.11) | 29.6817 |
| 2010's | 22 (61.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balfagón, G; Ballesteros, S; Benito, M; Blanco-Rivero, J; Cachofeiro, V; de las Heras, N; Gómez-Hernández, A; Lahera, V; Martín-Fernández, B; Valero-Muñoz, M | 1 |
| Capoulade, R; Chan, KL; Clavel, MA; Côté, N; Després, JP; Dumesnil, JG; Mathieu, P; Pibarot, P; Tam, JW; Teo, KK | 1 |
| Jialal, I; Sheely, D | 1 |
| Bajaj, M; Birnbaum, Y; Ling, S; Nanhwan, MK; Perez-Polo, JR; Ye, Y | 1 |
| Planchon, SM | 1 |
| Elisaf, MS; Kostapanos, MS; Lagos, KG; Milionis, HJ; Rizos, CB; Tselepis, AD | 1 |
| Busija, DW; Domoki, F; Gáspár, T; Katakam, PV; Mayanagi, K | 1 |
| Baboolal, K; Dunseath, G; Luzio, S; Moore, R; Owens, D; Ravindran, V; Sharif, A | 1 |
| Agouridis, AD; Elisaf, MS; Kostapanos, MS; Milionis, HJ; Rizos, CV | 1 |
| Baker, WL; Coleman, CI; Talati, R; White, CM | 1 |
| Bellia, A; Cardillo, C; Donadel, G; Fabiano, R; Galli, A; Lauro, D; Lombardo, MF; Rizza, S; Sbraccia, P; Tesauro, M | 1 |
| Yalta, K | 1 |
| Koh, KK; Quon, MJ; Sakuma, I | 1 |
| Anagnostis, P; Athyros, VG; Karagiannis, A; Mikhailidis, DP | 1 |
| Kim, H; Kim, YK; Park, JB; Rhee, EJ; Rosenson, RS; Sung, KC | 1 |
| Arai, H; Minami, M; Murayama, T; Tamura, Y; Yokode, M | 1 |
| Elisaf, M; Kei, AA; Kostapanos, MS; Liberopoulos, E; Mikhailidis, DP; Milionis, H; Moutzouri, E | 1 |
| Choi, H; Han, SH; Koh, KK; Lee, K; Quon, MJ; Sakuma, I; Shin, EK | 1 |
| Aguila, MB; Fraulob, JC; Mandarim-de-Lacerda, CA; Souza-Mello, V | 1 |
| Andreadi, K; Bellia, A; Cardillo, C; Donadel, G; Fabiano, R; Federici, M; Lauro, D; Lombardo, MF; Quon, MJ; Rizza, S; Sbraccia, P; Tesauro, M | 1 |
| Chi, J; Guo, H; Ji, Z; Liu, L; Lv, H; Peng, F; Tang, W; Xu, F; Zhai, X | 1 |
| Chang, TI; Doh, FM; Han, DS; Han, SH; Kang, SW; Kim, CH; Ko, KI; Koo, HM; Lee, MJ; Oh, HJ; Shin, DH; Yoo, TH | 1 |
| Barkas, F; Elisaf, MS; Liamis, G; Liberopoulos, EN; Moutzouri, E; Rizos, CV | 1 |
| Ikizler, TA; King-Morris, K | 1 |
| Elisaf, MS; Florentin, M; Kei, AA; Kostapanos, MS; Liamis, G; Liberopoulos, EN; Rizos, CV | 1 |
| Zateĭshchikov, DA | 1 |
| Avogaro, A | 1 |
| Busija, DW; Miller, AW; Tulbert, CD | 1 |
| SoRelle, R | 1 |
| Abbasi, F; Cain, V; Chu, JW; Hutchinson, H; Lamendola, C; Leary, E; McLaughlin, T; Reaven, G; Stein, E | 1 |
| Adeli, K; Cheung, RC; Chong, T; Federico, L; Naples, M; Smith, GJ; Taylor, D | 1 |
| Abbink, EJ; de Graaf, J; Holewijn, S; Stalenhoef, AF; Tack, CJ; ter Avest, E | 1 |
| Busija, DW; Erdös, B; Katakam, P; Miller, AW; Snipes, JA; Tulbert, CD | 1 |
| Cooper, SA; DeMarco, VG; Hayden, MR; Lastra, G; Manrique, C; Nistala, R; Sowers, JR; Wei, Y; Westerly, B; Whaley-Connell, A; Wiedmeyer, C | 1 |
| Adeli, K; Federico, LM; Naples, M; Nelken, J; Xu, E | 1 |
| Boulanger, M; Della-Zuana, O; Duhault, J; Espinal, J; Lacour, F; Ravel, D; Wierzbicki, M | 1 |
4 review(s) available for fluorobenzenes and Insulin Resistance
| Article | Year |
|---|---|
Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis.
Topics: Anticholesteremic Agents; Blood Glucose; Blood Pressure; Body Size; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Male; Patient Selection; Pravastatin; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Triglycerides | 2010 |
Differential metabolic effects of distinct statins.
Topics: Adiponectin; Animals; Atorvastatin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Fluorobenzenes; Heptanoic Acids; Homeostasis; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Mice; Pravastatin; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2011 |
[Features of the use of rosuvastatin in clinical practice].
Topics: Biological Availability; Cardiovascular Diseases; Comorbidity; Fluorobenzenes; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Metabolic Clearance Rate; Pharmacogenetics; Pharmacovigilance; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tissue Distribution; Treatment Outcome | 2012 |
[Diabetes and multimetabolic syndrome].
Topics: Diabetes Mellitus; Fluorobenzenes; Humans; Hypercholesterolemia; Hyperlipidemias; Insulin Resistance; Metabolic Syndrome; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2003 |
12 trial(s) available for fluorobenzenes and Insulin Resistance
| Article | Year |
|---|---|
Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial.
Topics: Adult; Aged; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Canada; Chi-Square Distribution; Disease Progression; Female; Fluorobenzenes; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertrophy, Left Ventricular; Insulin Resistance; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Pyrimidines; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Severity of Illness Index; Sulfonamides; Time Factors; Ultrasonography; Ventricular Function, Left; Ventricular Remodeling | 2013 |
Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia.
Topics: Adult; Cholesterol, LDL; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Insulin Resistance; Lipoproteins, LDL; Male; Middle Aged; Particle Size; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triglycerides | 2008 |
The effect of rosuvastatin on insulin sensitivity and pancreatic beta-cell function in nondiabetic renal transplant recipients.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Cross-Over Studies; Female; Fluorobenzenes; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Insulin-Secreting Cells; Kidney Transplantation; Lipids; Male; Middle Aged; Pyrimidines; Regression Analysis; Rosuvastatin Calcium; Sulfonamides | 2009 |
Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes.
Topics: Adiponectin; Adult; Blood Glucose; C-Reactive Protein; Cholesterol, LDL; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Lipids; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Tumor Necrosis Factor-alpha; Vasodilation | 2010 |
Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance.
Topics: Aged; Azetidines; Blood Glucose; Body Mass Index; Cholesterol, LDL; Drug Combinations; Ezetimibe; Fasting; Female; Fluorobenzenes; Homeostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Male; Medication Adherence; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome | 2011 |
Differential metabolic effects of rosuvastatin and pravastatin in hypercholesterolemic patients.
Topics: Female; Fluorobenzenes; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin Resistance; Male; Middle Aged; Pravastatin; Pyrimidines; Rosuvastatin Calcium; Single-Blind Method; Sulfonamides | 2013 |
Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy.
Topics: Adiponectin; Biomarkers; Blood Glucose; Brachial Artery; C-Reactive Protein; Chi-Square Distribution; Cross-Over Studies; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Fluorobenzenes; Glucose Clamp Technique; Glycated Hemoglobin; Homeostasis; Hospitals, University; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Leptin; Lipids; Male; Middle Aged; Pyrimidines; Rome; Rosuvastatin Calcium; Simvastatin; Single-Blind Method; Sulfonamides; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2012 |
The effect of HMG-CoA reductase inhibitor on insulin resistance in patients undergoing peritoneal dialysis.
Topics: Adipokines; Adult; Body Mass Index; Enzyme-Linked Immunosorbent Assay; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Insulin Resistance; Male; Middle Aged; Peritoneal Dialysis; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2012 |
Effects of manidipine plus rosuvastatin versus olmesartan plus rosuvastatin on markers of insulin resistance in patients with impaired fasting glucose, hypertension, and mixed dyslipidemia.
Topics: Aged; Blood Glucose; Dihydropyridines; Drug Therapy, Combination; Dyslipidemias; Endpoint Determination; Fasting; Female; Fluorobenzenes; Humans; Hypertension; Imidazoles; Insulin Resistance; Male; Middle Aged; Nitrobenzenes; Piperazines; Prospective Studies; Pyrimidines; Rosuvastatin Calcium; Single-Blind Method; Sulfonamides; Tetrazoles; Treatment Outcome | 2013 |
Colesevelam plus rosuvastatin 5 mg/day versus rosuvastatin 10 mg/day alone on markers of insulin resistance in patients with hypercholesterolemia and impaired fasting glucose.
Topics: Aged; Allylamine; Anticholesteremic Agents; Biomarkers; Blood Glucose; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fasting; Female; Fluorobenzenes; Glucose Intolerance; Humans; Hypercholesterolemia; Insulin Resistance; Male; Middle Aged; Prediabetic State; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2013 |
Comparative effects of rosuvastatin and gemfibrozil on glucose, insulin, and lipid metabolism in insulin-resistant, nondiabetic patients with combined dyslipidemia.
Topics: Apolipoproteins; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Female; Fluorobenzenes; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Insulin; Insulin Resistance; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Triglycerides | 2005 |
Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH).
Topics: Adult; Aged; Brachial Artery; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Insulin Resistance; Male; Middle Aged; Placebos; Plethysmography; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome; Ultrasonography; Vasodilation | 2005 |
20 other study(ies) available for fluorobenzenes and Insulin Resistance
| Article | Year |
|---|---|
Factors involved in rosuvastatin induction of insulin sensitization in rats fed a high fat diet.
Topics: Adipokines; Adipose Tissue, White; Animals; Diet, High-Fat; Down-Regulation; Endothelium, Vascular; Fluorobenzenes; Glucose Transporter Type 4; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Insulin Resistance; Male; MAP Kinase Signaling System; Overweight; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Pyrimidines; Rats; Rats, Wistar; Rosuvastatin Calcium; Sirtuin 1; Sulfonamides; Transcription Factors; Vasodilation | 2013 |
Strategies to lower low-density lipoprotein cholesterol in metabolic syndrome: averting the diabetes risk.
Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Female; Fluorobenzenes; Glucose Intolerance; Humans; Hypercholesterolemia; Insulin Resistance; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2013 |
PTEN upregulation may explain the development of insulin resistance and type 2 diabetes with high dose statins.
Topics: Animals; Blood Glucose; Cilostazol; Diabetes Mellitus, Type 2; Diet, Western; Fluorobenzenes; Gene Knockdown Techniques; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Mice; Muscle, Skeletal; Phosphodiesterase 3 Inhibitors; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Tetrazoles; Up-Regulation | 2014 |
Abrogating the induction of type 2 diabetes mellitus secondary to statin therapy.
Topics: Animals; Diabetes Mellitus, Type 2; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; PTEN Phosphohydrolase; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Up-Regulation | 2014 |
Acute treatment with rosuvastatin protects insulin resistant (C57BL/6J ob/ob) mice against transient cerebral ischemia.
Topics: Animals; Blood Glucose; Blotting, Western; Cerebrovascular Circulation; Cholesterol; Disease Models, Animal; Endothelium, Vascular; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Ischemic Attack, Transient; Laser-Doppler Flowmetry; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Nitric Oxide Synthase; Obesity; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides; Time Factors | 2008 |
Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose.
Topics: Adolescent; Adult; Aged; Blood Glucose; Fasting; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Young Adult | 2009 |
Insulin resistance due to statin therapy: a potential contributor to the negation of statin-induced beneficial effects on cardiac remodelling in heart failure?
Topics: Fluorobenzenes; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Ventricular Remodeling | 2011 |
Impact of statins on glucose metabolism--a matter of debate.
Topics: Atorvastatin; Fluorobenzenes; Glucose; Heptanoic Acids; Homeostasis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides | 2011 |
Prevalence of low LDL-cholesterol levels and elevated high-sensitivity C-reactive protein levels in apparently healthy Korean adults.
Topics: Asian People; Blood Pressure; C-Reactive Protein; Cholesterol, LDL; Cohort Studies; Dyslipidemias; Female; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Male; Middle Aged; Pyrimidines; Republic of Korea; Rosuvastatin Calcium; Sulfonamides; Surveys and Questionnaires | 2012 |
Differential effect of statins on diabetic nephropathy in db/db mice.
Topics: Adiposity; Albuminuria; Animals; Blood Pressure; Body Weight; Creatinine; Diabetic Nephropathies; Fluorobenzenes; Insulin Resistance; Male; Mice; Oxidative Stress; Pravastatin; Pyrimidines; Quinolines; Real-Time Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides | 2011 |
Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet.
Topics: Adipokines; Adipose Tissue; Adiposity; Animals; Blood Glucose; Body Composition; Diet, High-Fat; Fatty Liver; Fluorobenzenes; Homeostasis; Insulin Resistance; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Pyrimidines; Resistin; Rosiglitazone; Rosuvastatin Calcium; Sterol Regulatory Element Binding Protein 1; Sulfonamides; Thiazolidinediones; Triglycerides | 2012 |
Rosuvastatin may modulate insulin signaling and inhibit atherogenesis beyond its plasma cholesterol-lowering effect in insulin-resistant mice.
Topics: Animals; Atherosclerosis; Diet; Fluorobenzenes; Fructose; Glucose Transporter Type 4; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipids; Liver; Male; Mice; Mice, Knockout; Proto-Oncogene Proteins c-akt; Pyrimidines; Receptors, LDL; Rosuvastatin Calcium; Sulfonamides | 2012 |
Insulin resistance in patients undergoing peritoneal dialysis: can we improve it? : editorial to: "the effect of HM-CoA reductase inhibitor on insulin resistance in patients undergoing peritoneal dialysis" by Fa Mee Doh et al.
Topics: Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Male; Peritoneal Dialysis; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2012 |
Rosuvastatin treatment reverses impaired coronary artery vasodilation in fructose-fed, insulin-resistant rats.
Topics: Acetylcholine; Animals; Cholesterol; Coronary Circulation; Coronary Vessels; Fluorobenzenes; Fructose; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipids; Male; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Pyrimidines; Rats; Rats, Sprague-Dawley; Rosuvastatin Calcium; Sulfonamides; Triglycerides; Vasodilation; Vasodilator Agents | 2004 |
Diagnosing familial combined hyperlipidemia.
Topics: Apolipoproteins B; Cardiology; Contraindications; Drug Labeling; Drug Resistance; European Union; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemia, Familial Combined; Insulin Resistance; Lipectomy; Obesity; Pyrimidines; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Sulfonamides; United States; United States Food and Drug Administration | 2004 |
Effect of rosuvastatin on hepatic production of apolipoprotein B-containing lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia.
Topics: Animals; Apolipoproteins B; Cells, Cultured; Chromatography, Gel; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Dyslipidemias; Electrophoresis, Polyacrylamide Gel; Fluorobenzenes; Hepatocytes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Liver; Male; Mesocricetus; Metabolic Syndrome; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2006 |
Rosuvastatin improves cerebrovascular function in Zucker obese rats by inhibiting NAD(P)H oxidase-dependent superoxide production.
Topics: Animals; Cerebral Arteries; Cerebrovascular Circulation; Diabetes Mellitus; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin Resistance; Male; NADPH Oxidases; Obesity; Pyrimidines; Rats; Rats, Zucker; Rosuvastatin Calcium; Sulfonamides; Superoxides; Treatment Outcome | 2006 |
Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury.
Topics: Albuminuria; Animals; Blood Glucose; Body Weight; Fluorobenzenes; Glomerular Filtration Rate; Homeostasis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Insulin Resistance; Male; Microscopy, Electron, Transmission; Obesity; Oxidative Stress; Podocytes; Pyrimidines; Rats; Rats, Zucker; Rosuvastatin Calcium; Sulfonamides; Superoxide Dismutase | 2008 |
Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: evidence for statin-induced hepatic insulin sensitization.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cricetinae; Disease Models, Animal; Fluorobenzenes; Fructose; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Injections, Intravenous; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Male; Mesocricetus; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Proto-Oncogene Proteins c-akt; Pyrimidines; Receptor, Insulin; Rosuvastatin Calcium; Signal Transduction; Sulfonamides; Triglycerides | 2008 |
S15261, a new compound for the treatment of the insulin resistance syndrome.
Topics: Animals; Blood Glucose; Blood Pressure; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Fluorenes; Fluorobenzenes; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; In Vitro Techniques; Infusions, Intravenous; Insulin; Insulin Resistance; Insulin Secretion; Islets of Langerhans; Liver Glycogen; Male; Obesity; Portal Vein; Rats; Rats, Sprague-Dawley; Syndrome; Triglycerides | 1994 |